| Date Filed | Type | Description |
| 07/29/2013 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 07/23/2013 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP has filed a Schedule 13D for Omthera Pharmaceuticals, Inc. |
| 07/22/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/18/2013 |
8-K
| Quarterly results |
| 07/18/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/18/2013 |
4
| BARRETT M JAMES (10% Owner) has filed a Form 4 on Omthera Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 5,833,213 shares
@ $0 |
|
| 07/18/2013 |
4
| BASKETT FOREST (10% Owner) has filed a Form 4 on Omthera Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 5,833,213 shares
@ $0 |
|
| 07/18/2013 |
4
| KERINS PATRICK J (10% Owner) has filed a Form 4 on Omthera Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 5,833,213 shares
@ $0 |
|
| 07/18/2013 |
4
| DRANT RYAN D (10% Owner) has filed a Form 4 on Omthera Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 5,833,213 shares
@ $0 |
|
| 07/18/2013 |
4
| KOLLURI KRISHNA KITTU (10% Owner) has filed a Form 4 on Omthera Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 5,833,213 shares
@ $0 |
|
| 07/18/2013 |
4
| MOTT DAVID M (10% Owner) has filed a Form 4 on Omthera Pharmaceuticals, Inc. |
| 07/18/2013 |
4
| SANDELL SCOTT D (10% Owner) has filed a Form 4 on Omthera Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 5,833,213 shares
@ $0 |
|
| 07/18/2013 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on Omthera Pharmaceuticals, Inc. |
| 07/18/2013 |
4
| Weller Harry R (10% Owner) has filed a Form 4 on Omthera Pharmaceuticals, Inc. |
| 07/18/2013 |
4
| NEW ENTERPRISE ASSOCIATES 13 LP (10% Owner) has filed a Form 4 on Omthera Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 5,833,213 shares
@ $0 |
|
| 07/18/2013 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/18/2013 |
4
| Machielse Bernardus N M (Executive VP and COO) has filed a Form 4 on Omthera Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 247,005 shares
@ $0
Exercised 221,404 options to buy
@ $2.08, valued at
$460.5k
|
|
| 07/18/2013 |
4
| SCHADE CHRISTIAN S (Executive VP and CFO) has filed a Form 4 on Omthera Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 341,893 shares
@ $0
Exercised 316,292 options to buy
@ $2.08, valued at
$657.9k
|
|
| 07/18/2013 |
4
| Davidson Michael H. (Executive VP & CMO) has filed a Form 4 on Omthera Pharmaceuticals, Inc. |
| 07/18/2013 |
4
| Seghezzi Graziano (Director) has filed a Form 4 on Omthera Pharmaceuticals, Inc. |
| 07/18/2013 |
4
| SOFINNOVA CAPITAL VI FCPR (10% Owner) has filed a Form 4 on Omthera Pharmaceuticals, Inc. |
| 07/18/2013 |
4
| Wisler Gerald (President and CEO) has filed a Form 4 on Omthera Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 661,546 shares
@ $0
Disposed/sold 331,963 shares
@ $0
Disposed/sold 26,382 shares
@ $0 |
|
| 07/18/2013 |
4
| HORNER GEORGE F III (Director) has filed a Form 4 on Omthera Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 204,308 shares
@ $0 |
|
| 07/18/2013 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 07/16/2013 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits |
| 07/11/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 07/09/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 06/27/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 06/13/2013 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
| 06/13/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 05/28/2013 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans |
| 05/28/2013 |
8-K
| Acquisition/merger/asset purchase announced|
Docs:
|
"Agreement and Plan of Merger, among Omthera Pharmaceuticals, Inc., Zeneca, Inc. and KAFA Acquisition Corp",
"Form of Contingent Value Rights Agreement, by and between Zeneca, Inc. and the Rights Agent",
"Stockholder Voting Agreement, by and between Zeneca, Inc. and Gerald L. Wisler",
"Stockholder Voting Agreement, by and between Zeneca, Inc. and Michael H. Davidson",
"Stockholder Voting Agreement, by and among Zeneca, Inc., New Enterprise Associates 13, L.P., and NEA Ventures 2001, Limited Partnership",
"Stockholder Voting Agreement, by and between Zeneca, Inc. and Sofinnova Capital VI FCPR" |
|
| 05/28/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 05/28/2013 |
10-Q
| Quarterly Report for the period ended March 31, 2013 |
|